BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37308042)

  • 1. HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability.
    Ibáñez R; Roura E; Acera A; Andújar M; Pavón MÀ; Bruni L; de Sanjosé S
    Prev Med; 2023 Aug; 173():107571. PubMed ID: 37308042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 4. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
    Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
    J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Home-Mailed Versus General Practitioner-Delivered Vaginal Self-Sampling Kit for Cervical Cancer Screening: A Cluster Randomized Controlled Trial with a Cost-Effectiveness Analysis.
    Boyard J; Caille A; Brunet-Houdard S; Sengchanh-Vidal S; Giraudeau B; Marret H; Rolland-Lozachmeur G; Rusch E; Gaudy-Graffin C; Haguenoer K
    J Womens Health (Larchmt); 2022 Oct; 31(10):1472-1480. PubMed ID: 35834620
    [No Abstract]   [Full Text] [Related]  

  • 9. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
    Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
    BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
    Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
    J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
    [No Abstract]   [Full Text] [Related]  

  • 14. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.
    Scarinci IC; Li Y; Tucker L; Campos NG; Kim JJ; Peral S; Castle PE
    Prev Med; 2021 Jan; 142():106358. PubMed ID: 33338505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
    Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    Andersson S; Belkić K; Mints M; Östensson E
    J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
    PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
    Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
    Front Public Health; 2022; 10():938272. PubMed ID: 36420004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.